ASYMPTOMATIC COMPLEX TESTICULAR NEOPLASIA ASSOCIATED WITH ORCHIEPIDIDYMITIS. CASE REPORT

  • S. IACOB “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • R. VRINCEANU “Grigore T. Popa” University of Medicine and Pharmacy Iasi
  • B. NOVAC “Grigore T. Popa” University of Medicine and Pharmacy Iasi
Keywords: ORCHIEPIDIDYMITIS, GERM CELL TUMOR, TREATMENT

Abstract

Testicular germ cells tumors (TGCTs) are rare (2-3 new cases per 100,000 men per year) accounting for 1-2% of male malignancies and ranking fourth among genitourinary cancers. Testicular cancer is the most common cancer in young men 15 to 35-year-old. With approximately 50% of the TGCTs being pure seminomas and 50% non-seminomas, “radical orchiectomy” provides the histological diagnosis and should be performed before any further treatment, unless the clinical situation requires immediate chemotherapy in patients with a clear germ cell malignancy based on elevated tumor markers. Any testicular mass of uncertain ranking must be explored by the inguinal approach to verify or exclude malignancy. We present the case of a 30-year-old patient admitted to the Urology unit of the “Dr. C.I. Parhon” Clinical Hospital for pain in the right hemiscrotum for two weeks. Physical examination revealed the increase in size and local inflammatory changes of the right hemiscrotum. Later during hospital stay, the patient mentioned that the hemiscrotum had been progressively increasing in size over the past 6 months. An ultrasound exam was performed, and serum tumor markers were determined. Based on the results, the patient underwent radical orchiectomy by inguinal approach.

Author Biographies

S. IACOB, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
Senior student

R. VRINCEANU, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
1. Department of Surgery (II)
“Dr. C.I. Parhon” Clinical Hospital Iasi
2. Department of Urology

B. NOVAC, “Grigore T. Popa” University of Medicine and Pharmacy Iasi

Faculty of Medicine
1. Department of Surgery (II)
“Dr. C.I. Parhon” Clinical Hospital Iasi
2. Department of Urology

References

1. Motzer R.J., et al., NCCN Clinical Practice Guidelines, testicular cancer, germ cell tumors, alpha-fetoprotein, lactate dehydrogenase, human chorionic gonadotropin, cisplatin, seminoma, nonseminoma. JNCCN 2009; 7: 672-693.
2. Oldenburg J, Fosså SD, Nuver J, et al. ESMO Guidelines Working Group. Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2013; 24(suppl 6): vi125-132.
3. Russell SS Testicular cancer: overview and implications for health care providers. Urol Nurs. 2014; 34(4): 172-176.
4. Kush Sachdeva, et al. NCCN Clinical Practice Guidelines in Oncology: Testicular Cancer. V 1.2014. Available at http://www.nccn.org/professionals/physician gls/ pdf/testicular.pdf. (Accessed: January 16, 2014).
5. S. Hinz, et al., The role of positron emission tomography in the evaluation of residual masses after chemotherapy for advanced stage seminoma. J Urol 2008; 179: 936-940.
6. A. Baletti, et al., Scrotal pain as the first clinical manifestation of testicular seminoma: A case report, J Ultrasound 2008; 11(3): 118-120.
Published
2017-12-22